Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Am J Clin Pathol
3 Ann Hematol
3 Blood
1 Bone Marrow Transplant
7 Br J Haematol
1 Cancer
1 Eur J Haematol
1 Exp Hematol
4 Int J Hematol
1 Leuk Lymphoma
1 Leukemia
1 N Engl J Med
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Clin Pathol

  1. FUENTES-CHAVEZ E, Mendez-Ramirez N, Maltez MM, Salazar-Riojas R, et al
    A Method for the Elution of Anti-CD20 With an EDTA/Glycine Acid Solution for Accurate Immunophenotyping of B Lymphocytes Sensitized With Rituximab.
    Am J Clin Pathol. 2022;157:685-690.
    PubMed         Abstract available

    Ann Hematol

  2. SHARMA R, Jani C
    Mapping incidence and mortality of leukemia and its subtypes in 21 world regions in last three decades and projections to 2030.
    Ann Hematol. 2022 May 10. pii: 10.1007/s00277-022-04843.
    PubMed         Abstract available

  3. BRAITSCH K, Schwarz A, Koch K, Hubbuch M, et al
    Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis.
    Ann Hematol. 2022;101:1311-1319.
    PubMed         Abstract available

  4. WATTEBLED KJ, Drumez E, Coiteux V, Magro L, et al
    Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.
    Ann Hematol. 2022;101:1321-1331.
    PubMed         Abstract available


  5. LAUKKANEN S, Bacquelaine Veloso A, Yan C, Oksa L, et al
    Combination therapies to inhibit LCK tyrosine kinase and mTOR signaling in T-cell Acute Lymphoblastic Leukemia.
    Blood. 2022 May 11. pii: 485213. doi: 10.1182/blood.2021015106.
    PubMed         Abstract available

  6. LI L, Kim JH, Lu W, Williams DM, et al
    HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.
    Blood. 2022;139:2797-2815.
    PubMed         Abstract available

  7. TYAGI A, Ly S, El-Dana F, Yuan B, et al
    Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML.
    Blood. 2022;139:2782-2796.
    PubMed         Abstract available

    Bone Marrow Transplant

  8. YOKOYAMA H, Kanaya M, Iemura T, Hirayama M, et al
    Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch.
    Bone Marrow Transplant. 2022 May 10. pii: 10.1038/s41409-022-01700.
    PubMed         Abstract available

    Br J Haematol

  9. YU Q, Yu D, Chen X
    Cup-shaped nuclei in acute promyelocytic leukaemia.
    Br J Haematol. 2022;197:389.

  10. ALTER BP, Giri N, McReynolds LJ, Altintas B, et al
    Fanconi anaemia: A syndrome with distinct subgroups.
    Br J Haematol. 2022;197:467-474.
    PubMed         Abstract available

  11. JACOBY E, Bielorai B, Hutt D, Itzhaki O, et al
    Parameters of long-term response with CD28-based CD19 chimaeric antigen receptor-modified T cells in children and young adults with B-acute lymphoblastic leukaemia.
    Br J Haematol. 2022;197:475-481.
    PubMed         Abstract available

  12. OERLEMANS S, Efficace F, Kieffer JM, Kyriakou C, et al
    International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
    Br J Haematol. 2022;197:431-441.
    PubMed         Abstract available

  13. LEW TE, Anderson MA
    Health-related quality of life for patients with chronic lymphocytic leukaemia - A critical outcome measure in the era of highly effective therapies.
    Br J Haematol. 2022;197:394-396.

  14. WEI H, Zhou C, Liu B, Lin D, et al
    The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm).
    Br J Haematol. 2022;197:442-451.
    PubMed         Abstract available

  15. PETERSEN MA, Rosenberg CA, Brondum RF, Aggerholm A, et al
    Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
    Br J Haematol. 2022;197:452-466.
    PubMed         Abstract available


  16. KENNEDY KR, Turner JH, MacDonald WBG, Claringbold PG, et al
    Long-term survival and toxicity in patients with neuroendocrine tumors treated with (177) Lu-octreotate peptide radionuclide therapy.
    Cancer. 2022;128:2182-2192.
    PubMed         Abstract available

    Eur J Haematol

  17. ARCURI LJ, Lerner D, Tavares RCBDS
    Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell
    Eur J Haematol. 2022 May 9. doi: 10.1111/ejh.13787.
    PubMed         Abstract available

    Exp Hematol

  18. SOOF CM, Spektor TM, Parikh SA, Slager SL, et al
    Serum B-Cell Maturation Antigen is an Independent Prognostic Marker in Previously Untreated Chronic Lymphocytic Leukemia.
    Exp Hematol. 2022 May 4. pii: S0301-472X(22)00205.
    PubMed         Abstract available

    Int J Hematol

  19. MIZUTA S, Ugai T, Kato H, Doki N, et al
    Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Int J Hematol. 2022 May 10. pii: 10.1007/s12185-022-03368.
    PubMed         Abstract available

  20. TACHIBANA T, Tanaka M, Hagihara M, Fujimaki K, et al
    Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation.
    Int J Hematol. 2022 May 9. pii: 10.1007/s12185-022-03377.
    PubMed         Abstract available

  21. ARAI Y, Chi S, Minami Y, Yanada M, et al
    FLT3-targeted treatment for acute myeloid leukemia.
    Int J Hematol. 2022 May 9. pii: 10.1007/s12185-022-03374.
    PubMed         Abstract available

  22. NGUYEN TTT, Tamai M, Harama D, Kagami K, et al
    Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system.
    Int J Hematol. 2022 May 6. pii: 10.1007/s12185-022-03369.
    PubMed         Abstract available

    Leuk Lymphoma

  23. LI Z, Peng L, Li Y, Zhang J, et al
    Lower tumor burden is associated with better cognitive function in patients with chronic phase chronic myeloid leukemia.
    Leuk Lymphoma. 2022 May 11:1-12. doi: 10.1080/10428194.2022.2070912.
    PubMed         Abstract available


  24. RUSYN L, Reinartz S, Nikiforov A, Mikhael N, et al
    The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia.
    Leukemia. 2022 May 6. pii: 10.1038/s41375-022-01586.
    PubMed         Abstract available

    N Engl J Med

  25. RODRIGUES GR, Mendonca TM
    Retinal Hemorrhages in Leukemia.
    N Engl J Med. 2022;386:e50.

    PLoS One

  26. MATOU-NASRI S, Najdi M, AlSaud NA, Alhaidan Y, et al
    Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling.
    PLoS One. 2022;17:e0267855.
    PubMed         Abstract available

  27. YAMAMOTO N, Kikuchi J, Furukawa Y, Shibayama N, et al
    Fast in-vitro screening of FLT3-ITD inhibitors using silkworm-baculovirus protein expression system.
    PLoS One. 2022;17:e0261699.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.